Quinn Opportunity Partners’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Quinn Opportunity Partners’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-66,162	Closed	-$69K	–	218
2019 Q1	$69K	Buy	+66,162	New	+$53.9K	0.01%	176

Quinn Opportunity Partners's OMED Position: Q2 2019 in Review

Quinn Opportunity Partners sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 66,162 shares — an estimated $69K sold.

Quinn Opportunity Partners first reported a position in OMED in Q1 2019 and held it in 1 quarter. The position peaked at $69K in Q1 2019. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Quinn Opportunity Partners reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Quinn Opportunity Partners sold 66,162 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $69K.
Quinn Opportunity Partners first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
Quinn Opportunity Partners's OncoMed Pharmaceuticals, Inc. position peaked at $69K in Q1 2019.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Quinn Opportunity Partners's 13F filing for Q2 2019, filed 9 Aug 2019.